-HTSC owns 15% of KRTL Biotech Inc. and is the best way for the individual investor to participate in its growth.
KRTL Biotech Inc is a U.S. research and development company now working in Korea through KRTL Asia, with a consortium of experienced Korean and US doctors and researchers dedicated to improving mankind’s debilitating physical and mental ailments with progressive holistic solutions. Their disciplines are in the CBD and Psilocybin arena and will study and work with these and other plant-based products.
We are a biotech company instituting a facet of studies, with pharmaceutical resources and technologies that will help synthesize our research and help expedite our goals. Our scientists are leaders in cancer and neurology research, with over 15 years of experience in CBD.
KRTL Biotech Inc. now has obtained a Ministry of Food and Drug Safety (MFDS), formerly known as the Korea Food & Drug Administration (KFDA) approval, and our team can commence research between psilocybin and CBD that will better assist the medical and psychological community in the treatment of specific disorders, which include but not limited to pain resulting from Cancer treatment, Autism, PTSD, ADHD, Depression, Addiction, improvement in concentration and other psychological illnesses.
KRTL Biotech will be partnering up with a multitude of universities and biotech companies to facilitate this venture.
Through our partnership with professionals in other industries such as marketing, manufacturing, cultivation, distribution, public markets, and corporate structure, we hold an advantage in comparison to other research and development companies because we understand the complete evolution of the product, from concept to a marketable item generating revenue.
Our board and partners have experience with collaboration agreements, licensing agreements, and creating equity arrangements. These are some areas that will create opportunities for the right entity ready to get involved.
We are eager to embark on this journey by uniting minds and developing groundbreaking answers to these areas, where science can truly shine.
KRTL Biotech Inc. is a 15% owned asset by Here